| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.065 | 0.2 |